Focus

Dermorphin.

Available Variants

5 mg

View lab reports Quality process

Research area: Focus

🛡️

For research purposes only. Not intended for use in humans or animals.

Neuroscience research

About Dermorphin

Dermorphin is studied in the context of neuroscience and cognitive research. Highly selective, extremely potent agonist at the mu-opioid receptor — roughly 30–40 times more potent than morphine as an analgesic in animal models. The D-Ala modification increases metabolic stability relative to endogenous enkephalins.

Research Application

Used in basic pharmacology as a research tool to study mu-opioid receptor binding and opioid structure-activity relationships — not pursued as a human therapeutic candidate, substantially because of its high misuse and dependence potential.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 5 mg

Form Lyophilized powder

Category Focus

Purity & Identity see lab reports →

Sequence / Structure Heptapeptide H-Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2. Contains D-alanine at position 2 — a D-amino acid first described in 1981 as unprecedented in a natural vertebrate peptide, conferring marked resistance to aminopeptidase degradation.

Regulatory Status Not an approved drug. The entire published human evidence base is a single, never-replicated 1985 intrathecal trial. Dermorphin is a highly potent opioid with genuine misuse potential: banned as a Class I substance in horse racing after being used illegally as a doping agent on racehorses in 2011–2013. This misuse risk must be explicitly considered in any research context.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Studies on neuroscience-related peptides are predominantly preclinical.

Montecucchi PC, et al. Int J Pept Protein Res. 1981;17(3):275–283. PMID 7287299

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Similar Peptides

Regeneration KPV View → Regeneration PE-22-28 View → Regeneration B7-33 View →

Question about Dermorphin?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview